Univ Tx Md Anderson Company Profile
What is the competitive landscape for UNIV TX MD ANDERSON
UNIV TX MD ANDERSON has four approved drugs.
Drugs and US Patents for Univ Tx Md Anderson
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Univ Tx Md Anderson | AMMONIA N 13 | ammonia n-13 | INJECTABLE;INTRAVENOUS | 203933-001 | Jun 27, 2014 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Univ Tx Md Anderson | FLUDEOXYGLUCOSE F18 | fludeoxyglucose f-18 | INJECTABLE;INTRAVENOUS | 203246-002 | Jan 13, 2014 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Univ Tx Md Anderson | FLUDEOXYGLUCOSE F18 | fludeoxyglucose f-18 | INJECTABLE;INTRAVENOUS | 203246-001 | Jan 13, 2014 | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.

